Physician

David Wayne Faber, M.D.

According to 2025 Medicare claims, David Faber, M.D. (NPI: 1811990450) practices ophthalmology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is ROCKY MOUNTAIN RETINA CONSULTANTS (NPI: 1710980354; TIN: 870302621) and primary practice location at 59102-2497.

Faber's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 698 traditional Medicare patients, billed 20,113 HCPCS/CPT codes, and received $3,601,644 in Medicare payments. The top billing code was J0177 (Injection, aflibercept hd, 1 mg). Part D data shows 433 prescription claims across 114 beneficiaries totaling $23,722 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 26 records totaling $19,575. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,503,420 to $3,601,644. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $24,392 and ending at $23,722. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	855	12,399	$2,503,420
2016	804	11,635	$2,519,036
2017	844	10,157	$2,578,923
2018	985	10,530	$2,994,107
2019	976	10,887	$3,045,420
2020	791	9,067	$2,726,587
2021	1,148	12,656	$3,809,593
2022	1,079	13,707	$4,190,239
2023	941	17,253	$4,065,488
2024	698	20,113	$3,601,644

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	82	285	$24,392
2016	86	246	$19,822
2017	87	228	$15,546
2018	99	275	$74,273
2019	103	278	$20,269
2020	75	249	$13,555
2021	119	426	$21,171
2022	103	407	$24,416
2023	130	462	$29,829
2024	114	433	$23,722

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0177	Injection, aflibercept hd, 1 mg	190	5,544	$264
67028	Injection of drug into eye	348	1,404	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	315	501	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	318	512	$63
92134	Imaging of retina	548	1,379	$29

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	70	2,720	$3,054
Brimonidine Tartrate	Brimonidine Tartrate	76	4,039	$2,133
Latanoprost	Latanoprost	113	6,305	$1,215
Timolol Maleate	Timolol Maleate	32	2,388	$586
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	38	1,724	$285

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$465	Alimera Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$19,110	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Wayne Faber, M.D.?

Tedicare shows public-source Medicare data for David Wayne Faber, M.D. (NPI 1811990450), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Wayne Faber, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Wayne Faber, M.D.?

David Wayne Faber, M.D. is linked to ROCKY MOUNTAIN RETINA CONSULTANTS (billing NPI 1710980354) in the available physician profile data.

Does David Wayne Faber, M.D. have Open Payments data?

David Wayne Faber, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.